Susan Asante-Abedi (Bentsi-Enchill)

Overview

Susan Asante-Abedi (Bentsi-Enchill) serves as Chief Strategy Officer at Medical Knowledge Group[1], with specialties in the pharmaceutical industry[2]. Asante-Abedi-Bentsi-Enchill has held this position since February 2022[3]. Prior to joining Medical Knowledge Group, Asante-Abedi-Bentsi-Enchill worked as EVP, Strategy & Insights at 81qd from July 2018 to March 2022[4], and spent thirteen years at IQVIA as Senior Principal from July 2005 to June 2018[5]. Earlier career positions included roles at Putnam Associates as Associate from 2002 to 2003[6], Kaiser Associates as Senior Consultant from 2000 to 2002[7], and Pfizer as Summer Marketing Manager in 2004[8]. Asante-Abedi-Bentsi-Enchill holds an MS from Harvard T.H. Chan School of Public Health awarded in 2005[9] and a BA in Chemistry from Smith College, completed between 1996 and 2000[10].

Career history

1. Chief Strategy Officer - MKG, 81qdFeb 2022 to presentMedical Knowledge Group
2. 8EVP, Strategy & InsightsJul 2018 to Mar 202281qd
3. ISenior PrincipalJul 2005 to Jun 2018IQVIA
4. Summer Marketing Manager2004 to 2004Pfizer
5. PAAssociate2002 to 2003Putnam Associates
6. KASenior Consultant2000 to 2002Kaiser Associates

Education

1. MAMS at Harvard T.H. Chan School of Public Health2005
2. BA1996 - 2000Chemistry·at Smith College
3. GIGhana International School